A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Pharmacodynamics, Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic condition that causes muscles to slowly weaken over time, often affecting the face, shoulders, and legs. This phase II clinical trial looks at whether an experimental medicine named RO7204239 can help adults living with FSHD. The main goal is to find out if the medicine is safe and if it can increase or preserve working muscle in the thighs, which are measured using MRI scans. Researchers will also check the drug's effect on other muscles across the body and monitor any side effects. Because this is a double-blind trial, some volunteers will receive the real medicine while others will receive an inactive dummy treatment (placebo). Neither the participants nor their doctors will choose who gets which treatment. Regular hospital visits, heart checks, and blood tests will be carried out to keep participants safe.
Auf einen Blick
Worum geht es in dieser Studie?
Facioscapulohumeral muscular dystrophy, usually shortened to FSHD, is a muscle-wasting condition. Over time, it causes muscles in the face, shoulder blades, upper arms, and legs to lose strength and shrink. Everyday tasks like lifting your arms, climbing stairs, or walking can become much harder. Right now, there is no cure, and treatments mainly focus on managing symptoms with physiotherapy and supportive gear.
This study tests a new trial medicine known as RO7204239 (also referred to as GYM329). The drug is designed to target myostatin, a natural protein in the body that stops muscles from growing too large. By blocking or reducing the activity of this protein, researchers hope the medicine might help people with FSHD keep their muscle strength or even rebuild healthy muscle mass.
During the trial, doctors will use painless MRI scans to take detailed pictures of muscles, particularly the large thigh muscles. They will measure whether the working muscle grows or if the amount of fat inside the muscle changes. They will also run regular blood tests and heart checks to make sure the treatment does not cause unwanted health issues.
Finding treatments that can slow down or reverse muscle loss could make a major difference to people with FSHD. While this trial is still an exploratory phase II study and cannot promise personal health benefits, the findings will help doctors learn whether this medicine could become a helpful future treatment.
Wichtige Erkenntnisse
- Tests a new trial medicine (RO7204239) designed to help protect or build muscle in adults with FSHD.
- Open to adults aged 18 and older with a confirmed diagnosis of FSHD.
- Uses MRI scans and regular health tests to see how muscles respond and ensure patient safety.
- Half of the participants may receive a dummy injection (placebo) instead of the active medicine.
- Participation is entirely voluntary, and you can leave the study at any time.
Wer könnte berechtigt sein?
This study is open to adults aged 18 and over who have been diagnosed with facioscapulohumeral muscular dystrophy (FSHD). Both men and women can take part.
Because this study relies heavily on MRI scans to see how well muscles are working, participants must be able to have standard MRI scans safely. People who have certain metal implants, pacemakers, or severe claustrophobia may not be able to join.
The trial team will also check your general health before you join. Having other serious medical conditions, such as severe heart, liver, or kidney problems, might mean the trial is not safe for you. Your study doctor will review your full medical history and current medications to confirm if you qualify.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- I am aged 18 or older.
- I have been diagnosed with facioscapulohumeral muscular dystrophy (FSHD).
- I am able to safely lie still for MRI scans (no metal implants that prevent scans).
- I am willing to attend regular hospital appointments for check-ups and injections.
- I am happy to undergo routine tests like blood samples and heart traces.
Was beinhaltet die Teilnahme?
Taking part involves regular visits to a specialist hospital or clinical trial clinic over several months. You will be given either the study medicine (RO7204239) or a matching dummy injection (placebo) under the skin. A computer decides who receives which treatment, and neither you nor your doctor will know which one you are receiving.
At your visits, the medical team will carry out health checks to monitor your safety. These include checking your blood pressure and temperature, testing your blood and urine, and doing heart tests such as ECGs (heart traces) and echocardiograms (heart ultrasound scans). You will also have MRI scans of your legs and other parts of your body so the team can measure your muscle size.
You will be asked to report any new symptoms or side effects, especially around the injection site. The study team will follow up on your health throughout the trial and for a period after your final dose to ensure you remain well.
Potenzielle Risiken und Vorteile
Standorte (2)
- —UnbestätigtItalien
- —UnbestätigtDänemark
Häufige Fragen
What is a placebo and why is it used?
A placebo is a harmless dummy treatment that looks just like the real medicine. Comparing the study drug to a placebo helps researchers know whether changes in muscle health are truly caused by the medicine.
Will having an MRI scan hurt?
No, MRI scans are completely painless. They use magnets and radio waves to take pictures of your muscles. You will just need to lie still inside the scanner while it makes tapping or buzzing noises.
Can I choose to receive the real medicine instead of the dummy drug?
No. To keep the trial fair and accurate, a computer randomly assigns which treatment you receive, and neither you nor your trial team can pick.
Will taking part cost me anything?
Trial medications and tests are provided free of charge. Most studies also help cover reasonable travel expenses to and from clinic appointments.
What happens if I change my mind after joining?
You are free to stop participating at any point. Deciding to leave will not affect your relationship with your doctors or the normal medical care you receive.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.